IL6 and prostate cancer: In addition, under long-term treatment conditions, IL-6 can activate its own gene expression and, in prostate cancer, autocrine and paracrine loops involving IL-6 and one of its multiple activators, the TGF-beta, have been implicated in the regulation of cell proliferation, survival, and neuroendocrine differentiation [12].